Video
Assess Stroke Risk, Benefit of Anticoagulation in Patients Ages 80 and Older With Atrial Fibrillation
Patients ages 80 and older have unique considerations when deciding whether to initiate anticoagulation therapy.
In an interview with Pharmacy Times, Zachary Noel, PharmD, BCCP, discussed the presentation at the American Society of Health-System Pharmacists 2021 Midyear Meeting titled "Direct Oral Anticoagulant Dilemmas: Stroke Prevention for Atrial Fibrillation in the Oldest Old and Patients with End-Stage Renal Disease."
In the interview, Noel discussed specific considerations for patients ages 80 and older, recommendations for anticoagulation initiation, and how to best assess stroke risk in these populations.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
